Cargando…
Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma
SIMPLE SUMMARY: Patients undergoing radiotherapy for head and neck cancer often develop painful mouth sores caused by inflammation called oral mucositis. The use of prophylactic gabapentin to reduce pain and opioid use during treatment in this population is controversial. To investigate this further...
Autores principales: | Qiu, Michelle L., Iovoli, Austin J., Khan, Michael, Farrugia, Mark K., Ma, Sung Jun, Singh, Anurag K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093545/ https://www.ncbi.nlm.nih.gov/pubmed/37046669 http://dx.doi.org/10.3390/cancers15072003 |
Ejemplares similares
-
Association of Gabapentin Use With Pain Control and Feeding Tube Placement Among Patients With Head and Neck Cancer Receiving Chemoradiotherapy
por: Ma, Sung Jun, et al.
Publicado: (2022) -
Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer
por: Iovoli, Austin J., et al.
Publicado: (2023) -
Prophylactic gabapentin during head and neck cancer therapy: a systematic review and meta-analysis
por: Smith, Loren E., et al.
Publicado: (2023) -
Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy
por: Iovoli, Austin J., et al.
Publicado: (2020) -
Machine Learning Incorporating Host Factors for Predicting Survival in Head and Neck Squamous Cell Carcinoma Patients
por: Yu, Han, et al.
Publicado: (2021)